Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

NCT01964326

Phase 3Completed1,311 people17 Oct 2013clinicaltrials.gov

NCT01838044

Phase 4Terminated180 people23 Apr 2013clinicaltrials.gov

NCT01062113

Phase 2Completed255 people4 Feb 2010clinicaltrials.gov

NCT00994461

Phase 4Completed190 people14 Oct 2009clinicaltrials.gov

NCT00976716

Phase 3Completed80 people14 Sept 2009clinicaltrials.gov

NCT00925106

Phase 1Completed16 people19 Jun 2009clinicaltrials.gov

NCT00917644

Phase 4Completed76 people10 Jun 2009clinicaltrials.gov

NCT00917579

Phase 4Completed76 people10 Jun 2009clinicaltrials.gov

NCT00894790

Phase 4Terminated8 people7 May 2009clinicaltrials.gov

NCT00844376

Phase 4Completed12 people16 Feb 2009clinicaltrials.gov

NCT00827606

Phase 3Completed272 people23 Jan 2009clinicaltrials.gov

NCT00807846

Phase 4Completed201 people12 Dec 2008clinicaltrials.gov

NCT00777517

Phase 1Completed76 people22 Oct 2008clinicaltrials.gov

NCT00762463

Phase 3Completed240 people30 Sept 2008clinicaltrials.gov

NCT00758004

Phase 1Completed76 people23 Sept 2008clinicaltrials.gov

NCT00739999

Phase 1Completed39 people22 Aug 2008clinicaltrials.gov

NCT00728988

Phase 4Completed499 people6 Aug 2008clinicaltrials.gov

NCT00662558

Phase 3Completed802 people21 Apr 2008clinicaltrials.gov

NCT00647543

Phase 4Completed242 people31 Mar 2008clinicaltrials.gov

NCT00645424

Phase 4Completed155 people27 Mar 2008clinicaltrials.gov